Global Live Cell Imaging Market Research Report: Products (Equipment, Consumables, Software), Technology (Fluorescence Recovery After Photobleaching (FRAP), Others), Application (Drug Discovery, Cell Biology, Others), End-User – Global Forecast Till 2023
pune, India - June 12, 2019 /MarketersMedia/ —
Market Synopsis:
Live cell imaging is a nascent technology which is poised to gain popularity in the upcoming years owing to increasing demand for healthcare services. Market Research Future (MRFR)’s study has revealed that the global live cell imaging market is projected to strike a healthy CAGR of 9% over the forecast period 2018 to 2023. The technology is excessively used for research & development purposes. Thus, proliferating applications across the healthcare sector is prognosticated which is anticipated to propel market expansion.
You Can Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6075
Increasing prevalence of chronic diseases is expected to intensify the need for the development of drugs and effective treatments. This, in turn, is projected to support the expansion of the live cell imaging market over the next couple of years. Also, technological advancements in imaging are projected to dominate the growth pattern of the market in the foreseeable future.
Investments in cell-based life science research projects are anticipated to have a favorable impact on the growth trajectory of the live cell imaging market across the review period. On the flip side, factors such as expensiveness of high-content screening systems and lack of skilled personnel are anticipated to check the expansion of the live cell imaging market in the forthcoming years.
Market Segmentation:
By product, the global live cell imaging market has been segmented into equipment, consumables, and software. The equipment segment has been sub-segmented into standalone systems, microscopes (confocal microscopes, conventional microscopes, and advanced fluorescence microscopes), cell analyzer, and image-capturing devices. The consumables segment is further sub-segmented into assay kits, media, reagents, and others.
The live cell imaging market, by technology, has been segmented fluorescence resonance energy transfer, high-content analysis, into fluorescence recovery after photobleaching, fluorescence in situ hybridization, ratiometric imaging, multiphoton excitation microscopy total internal reflection fluorescence microscopy, and other technologies.
By application, the global live cell imaging market has been segmented into stem cells, cell biology, developmental biology, and drug discovery.
On the basis of end-user, the live cell imaging market has been segmented into biotechnology companies, hospitals, pharmaceutical companies, diagnostic laboratories, and others.
Inquire Here For Queries Or Report Customization: https://www.marketresearchfuture.com/enquiry/6075
Regional Analysis:
By region, the global live cell imaging market has been segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa (MEA). Americas hold the lion’s share of the market owing to the presence of well-developed healthcare infrastructure in the region. Technological advancements and increasing patient population are anticipated to catapult the regional live cell imaging market on an upward trajectory. Europe is forecasted to maintain its position at the second spot over the assessment period. Research & development in the region is poised to propel the expansion of the market in the region. Similarly, Asia Pacific is projected to exhibit substantial growth across the review period. However, the Middle East & Africa is expected to grow at a limited pace in the upcoming years.
Competitive Dashboard:
The important players operating in the global live cell imaging market include Leica Microsystems (Germany), Carl Zeiss AG (Germany), Olympus Corporation (Japan), Nikon Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Molecular Devices, LCC (U.S.), GE Healthcare (U.K.), PerkinElmer, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and BioTek Instruments (U.S.).
Industry News:
In May 2018, Carl Zeiss (branded as ZEISS), a German manufacturer of optical systems & medical devices, presented its ZEISS X-ray Series portfolio which offers complete solutions - from Nano to macro in 2D and 3D.
In May, ZEISS Medical Technology announced breakthroughs in high-resolution imaging and digital technologies at the American Society of Cataract and Refractive Surgery.
In December 2018, Molecular Devices, a supplier of bioanalytical measurement systems for other life sciences research and drug discovery, announced z-stack acquisition for the ImageXpress® Pico system at ASCB | EMBO 2018 held in San Diego, California.
Read Complete Report @ https://www.marketresearchfuture.com/reports/live-cell-imaging-market-6075
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: WantStats Research and Media Pvt. Ltd. Office No. 528, Amanora Chambers
Phone: 6468459312
Website: https://www.marketresearchfuture.com/
Source: MarketersMedia
Release ID: 523432
